Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0NNKKE
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
CN115429890B ADC-2
|
|||||
| Synonyms |
ADC-2
Click to Show/Hide
|
|||||
| Organization |
Liaoning Kai Kai Technology Co ltd
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
4
|
|||||
| Antibody Name |
undisclosed
|
|||||
| Antigen Name |
Epidermal growth factor receptor (EGFR)
|
Antigen Info | ||||
| Payload Name |
Active metabolite of irinotecan SN38
|
Payload Info | ||||
| Therapeutic Target |
DNA topoisomerase 1 (TOP1)
|
Target Info | ||||
| Linker Name |
DBCO-Val-Cit-PABC
|
Linker Info | ||||
| Combination Type |
DBCO-VC-PAB-SN38
|
|||||